{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:03:03Z","timestamp":1774080183612,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10072-026-08854-3","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:46:45Z","timestamp":1770256005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sleep quality improvement after switching from levodopa\/carbidopa intestinal gel to continuous subcutaneous foslevodopa\/foscarbidopa infusion in advanced Parkinson\u2019s disease: a case report"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0478-4523","authenticated-orcid":false,"given":"Lanfranco","family":"De Carolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Pacilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-087X","authenticated-orcid":false,"given":"Domiziana","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"8854_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JPD-225105","volume":"13","author":"KR Chaudhuri","year":"2023","unstructured":"Chaudhuri KR, Kov\u00e1cs N, Pontieri FE et al (2023) Levodopa carbidopa intestinal gel in advanced parkinson\u2019s disease: DUOGLOBE final 3-Year results. J Parkinsons Dis 13:769\u2013783. https:\/\/doi.org\/10.3233\/JPD-225105","journal-title":"J Parkinsons Dis"},{"key":"8854_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2022.03.012","volume":"97","author":"M Rosebraugh","year":"2022","unstructured":"Rosebraugh M, Stodtmann S, Liu W, Facheris MF (2022) Foslevodopa\/foscarbidopa subcutaneous infusion maintains equivalent Levodopa exposure to Levodopa-carbidopa intestinal gel delivered to the jejunum. Parkinsonism Relat Disord 97:68\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.03.012","journal-title":"Parkinsonism Relat Disord"},{"key":"8854_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s40263-025-01179-3","volume":"39","author":"HA Blair","year":"2025","unstructured":"Blair HA (2025) Foslevodopa\/Foscarbidopa: A review in advanced parkinson\u2019s disease. CNS Drugs 39:621\u2013632. https:\/\/doi.org\/10.1007\/s40263-025-01179-3","journal-title":"CNS Drugs"},{"key":"8854_CR4","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.prdoa.2024.100239","volume":"10","author":"VSC Fung","year":"2024","unstructured":"Fung VSC, Aldred J, Arroyo MP et al (2024) Continuous subcutaneous foslevodopa\/foscarbidopa infusion for the treatment of motor fluctuations in parkinson\u2019s disease: considerations for initiation and maintenance. Clin Parkinsonism Relat Disorders 10:100239. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100239","journal-title":"Clin Parkinsonism Relat Disorders"},{"key":"8854_CR5","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41598-024-54299-z","volume":"14","author":"S Szatm\u00e1ri","year":"2024","unstructured":"Szatm\u00e1ri S, Sz\u00e1sz JA, Orb\u00e1n-Kis K et al (2024) Starting with 24-h Levodopa carbidopa intestinal gel at initiation in a large cohort of advanced parkinson\u2019s disease patients. Sci Rep 14:3676. https:\/\/doi.org\/10.1038\/s41598-024-54299-z","journal-title":"Sci Rep"},{"key":"8854_CR6","doi-asserted-by":"publisher","unstructured":"Baille G, Patte-Karsenti N, Salardaine Q et al (2025) Switching from Levodopa\/Carbidopa intestinal gel to continuous subcutaneous Foslevodopa\/Carbidopa infusion in advanced parkinson\u2019s disease: A case series. https:\/\/doi.org\/10.1002\/mdc3.70317. Movement Disorders Clinical Practice n\/a","DOI":"10.1002\/mdc3.70317"},{"key":"8854_CR7","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/mdc3.70324","volume":"12","author":"P Solla","year":"2025","unstructured":"Solla P, Velucci V, Defazio G, Ercoli T (2025) Navigating the neuropsychiatric risks of Foslevodopa\/Foscarbidopa in patients with parkinson\u2019s disease. Mov Disorders Clin Pract 12:2028\u20132029. https:\/\/doi.org\/10.1002\/mdc3.70324","journal-title":"Mov Disorders Clin Pract"},{"key":"8854_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/mdc3.70060","volume":"12","author":"S Broh\u00e9e","year":"2025","unstructured":"Broh\u00e9e S, Roze E, Grabli D et al (2025) Cognitive and psychiatric adverse effects of Foslevodopa\/Foscarbidopa in patients with parkinson\u2019s disease. Mov Disord Clin Pract 12:1028\u20131030. https:\/\/doi.org\/10.1002\/mdc3.70060","journal-title":"Mov Disord Clin Pract"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08854-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:36:01Z","timestamp":1774074961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08854-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8854"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08854-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient for case description and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"233"}}